Butyric acid in functional constipation

Przeglad Gastroenterologiczny

Volumn 8, Issue 5, 2013, Pages 295-298

  Pituch, Aleksandra ^a   Walkowiak, Jarosław ^b   Banaszkiewicz, Aleksandra ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Butyric acid; Defecation disorders; Sodium butyrate

Indexed keywords

BUTYRIC ACID; ENEMA; LACTULOSE; MACROGOL; MYELOPEROXIDASE; PLACEBO; SHORT CHAIN FATTY ACID;

ABDOMINAL PAIN; ANTIINFLAMMATORY ACTIVITY; BLADDER AND BOWEL MANAGEMENT; BLOATING; CONSTIPATION; DEFECATION; DISEASE ASSOCIATION; ENERGY RESOURCE; ENZYME ACTIVITY; FEEDING BEHAVIOR; FLUID INTAKE; FUNCTIONAL CONSTIPATION; GASTROINTESTINAL ABSORPTION; HUMAN; INFLAMMATION; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE MUCOSA; IRRITABLE COLON; LIFESTYLE MODIFICATION; MALAISE; MOTOR DYSFUNCTION; PAIN; PHYSICAL ACTIVITY; REVIEW; SMOOTH MUSCLE CONTRACTILITY; THERAPY EFFECT; TREATMENT DURATION;

EID: 84889842703     PISSN: 18955770     EISSN: 18974317     Source Type: Journal    
DOI: 10.5114/pg.2013.38731     Document Type: Review

References (24)

1. Rowe WA, Bayless TM. Colonic short-chain fatty acids: fuel from the lumen? Gastroenterology 1992; 103: 336-9.
2. Rechkemmer G, Ronnau K, von Englehardt W. Fermentation of polisaccharides and absorption of short chain fatty acids in the mammalian hindgut. Comp Biochem Physiol 1988; 90A: 563-8.
3. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001; 81: 1031-64.
4. Pryde SE, Duncan SH, Hold GL, et al. The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 2002; 217: 133-9.
5. Roy CC, Kien CL, Bouthillier L, et al. Short-chain fatty acids: ready for prime time? Nutr Clin Pract 2006; 21: 351-66.
6. Hold GL, Schwiertz A, Aminov RI, et al. Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl Environ Microb 2003; 69: 4320-4.
7. Roediger WE. Role of aerobic bacteria In the metabolic welfare of colonic mucosa in man. Gut 1980; 21: 793-8.
8. Scheppach W, Bartram P, Richter A, et al. Effect of short-chain fatty acids on the human colonic mucosa in vitro. J Parenter Enteral Nutr 1992; 16: 43-8.
9. Charney AN, Micic L, Egnor RW. Nonionic diffusion of shortchain fatty acids cross rat colon. Am J Physiol Gastroenterol Liver Physiol 1998; 274: G518-24.
10. Peppas G, Alexiou VG, Mourtzoukou E, et al. Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol 2008; 8: 5.
11. http://www.romecriteria.org/criteria/
12. Librach SL, Bouvette M, De Angelis C, et al. Canadian Consensus Development Group for Constipation in Patients with Advanced Progressive Illness. Consensus recommendations for the management of constipation in patients with advanced, progressive illness. J Pain Symptom Manage 2010; 40: 761-73.
13. Dzierżanowski T, Rydzewska G. Constipation - a difficult therapeutic problem. Prz Gastroenterol 2012; 7: 249-63.
14. Banasiewicz T, Kaczmarek E, Maik J, et al. Jakość życia i objawy kliniczne u chorych z zespołem jelita nadwrażliwego leczonych uzupełniaja̧co chronionym maślanem sodu [Polish] Gastr Prakt 2011; 3: 45-53.
15. Vanhoutvin SA, Troost FJ, Kilkens TO, et al. The effects of butyrate enemas on visceral perception in healthy volunteers. Neurogastroenterol Motil 2009; 9: 952-e76.
16. Lührs H, Gerke T, Müller JG, et al. Butyrate inhibits NK-kappa B activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 2002; 37: 458-66.
17. Säemann MD, Böhmig GA, Osterreicher CH, et al. Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J 2000; 14: 2380-2.
18. Ogawa H, Rafiee P, Fisher PJ, et al. Butyrate modulates gene and protein expression in human intestinal endothelial cells. Biochem Biophys Res Commun 2003; 309: 512-9.
19. De Giorgio BG, Stanghellini V, Cremon C, et al. A role for inflammation in irritable bowel syndrome? Gut 2002; 51: 41-4.
20. Banasiewicz T, Borycka-Kiciak K, Dobrowolska-Zachwieja A, et al. Clinical aspects of sodium butyrate application in dietary treatment of bowel diseases. Prz Gastroenterol 2010; 5: 329-34.
21. Kristjánsson G, Venge P, Wanders A, et al. Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome. Gut 2004; 53: 1806-12.
22. Willemsen LE, Koetsier MA, van Deventer SJ, et al. Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. Gut 2003; 52: 1442-7.
23. Bajka BH, Clarke JM, Topping DL, et al. Butyrylated starch increases large bowel butyrate levels and lowers colonic smooth muscle contractility in rats. Nut Res 2010; 30: 427-34.
24. Knudsen KE, Serena A, Canibe N, et al. New insight into butyrate metabolism. Pro Nutr Soc 2003; 62: 81-6.